ZURA Zura Bio Limited - Class A1.44+0.20 (+16.1%)
ZURA Zura Bio Limited - Class A1.14-2.95 (-72.1%)
Premarket Decliner
ZURA Zura Bio Limited - Class A4.09+0.37+10.0%
Premarket:1.32-2.77 (-67.7%)
Zura Bio Provides Clinical Update on Phase 2 TibuSHIELD Study of Tibulizumab (ZB-106) in Hidradenitis Suppurativa
Business WireMon, 9-Nov 7:00 AM
ZURA Zura Bio Limited - Class A4.14+0.42 (+11.3%)
ZURA Zura Bio Limited - Class A3.83-0.52 (-12.0%)
ZURA Zura Bio Limited - Class A4.34+0.07 (+1.6%)
